As regards cytokine signaling, JAK-STAT pathway is activated in T-ALL and about 5% of cases are driven by tyrosine kinase oncogene fusions, particularly the NUP214-ABL1 rearrangement (86). This evidence concerns the gene NUP214 and acute lymphoblastic leukemia.